$NGVT

Ingevity Corp (NGVT): Results of Operations and Financial Condition

Ingevity Corp (NGVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99106302026.htm EX-99.1 Document Exhibit 99.1 Ingevity Corporation 4920 O'Hear Avenue Suite 400 North Charleston, SC 29405 USA www.ingevity.com Ingevity reports second quarter 2026 financial results Second Quarter 2026 Results and Recent Highlights: • Net sales of $31

Original reporting
Published Jul 29, 2026, 9:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 9:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$NGVT
Bullish
high confidence
Mentioned
$NGVT
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NGVTBullishMed
01

Why it matters

The key tradable elements are the raised full-year adjusted EBITDA range, improved adjusted EBITDA margin, and stated leverage improvement, partially offset by negative operating cash flow due to a litigation settlement payment.

02

Market read

Guidance and profitability metrics provide a fresh decision point for positioning ahead of the July 30 webcast and subsequent earnings expectations.

03

What to watch

Segment volatility remains: Pavement Technologies sales declined 22% and Advanced Polymer Technologies EBITDA margin surged from 4.6% to 22.7%, so traders may watch for sustainability versus one-time drivers like competitor supply disruptions and boiler downtime effects.

Relevance 7/10Novelty 8/10Timing: after-hours following the Q2 2026 8-K and guidance raise

Background

This is an SEC Form 8-K (Item 2.02) with Q2 2026 financial results and an updated full-year 2026 outlook, including the impact of the April 15, 2026 Road Markings divestiture.

Company-level read

Ticker impact

$NGVTBullishHigh confidence
Context

Ingevity reports Q2 2026 results and raises full-year adjusted EBITDA outlook to $380 to $400 million after a Road Markings divestiture.

Expected impact

Likely positive near-term bias as guidance is increased and divestiture effects clarify segment outlook.

Evidence & confidence

The filing includes specific Q2 datapoints (adjusted EBITDA $115.0m, margin 36.6%) and a concrete full-year adjusted EBITDA range increase, plus stated leverage improvement and planned use of free cash flow.

Market effects

Signals demand and pricing resilience in Performance Materials and improving profitability in Advanced Polymer Technologies, while Pavement Technologies remains pressured by divestiture and regional weakness.

Notes regional strength in North America but weakness in China and South America within Pavement Technologies, which may affect regional read-through for similar materials suppliers.

PFAS filtration contract mention supports ongoing investment interest in carbon technologies, though it is framed as early validation rather than quantified revenue.

Counterpoint

The guidance raise is paired with measured second-half outlook and negative operating cash flow driven by a litigation settlement, which could temper enthusiasm.

Key entities

  • Ingevity Corporation

    Reports Q2 2026 results, completes Road Markings divestiture, and raises full-year adjusted EBITDA outlook.

Related articles

$NGVTMedAI 8/10

Ingevity (NGVT) Q2 2026 Earnings Call Transcript

Ingevity (NGVT) held its Q2 2026 earnings call. Net sales were $314 million, down 5% on reported basis due to the Road Markings divestiture. Adjusted EBITDA rose 14% to $115 million, with margin at 36.6%. Adjusted EPS was $1.74. Free cash flow was $89 million. Full-year guidance for EBITDA and EPS was raised.

$NGVTMedAI 8/10

Ingevity Q2 Earnings Call Highlights

Ingevity (NYSE:NGVT) reported Q2 cash flow excluding a litigation settlement of about $89M, or $2.52/share, with capex near $10M. Performance Materials sales rose 4% to $161M, with segment EBITDA up 6% to $86M and margin to 53.6%. The company raised 2026 outlook to adjusted EBITDA $380M-$400M and EPS $5.00-$5.45, plus free cash flow $220M-$245M.

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.

$DBXMed

Dropbox Shares Decline Despite Earnings Beat as Revenue Growth Disappoints

Dropbox (DBX) shares fell about 5% premarket to around $32.80 after Q2 2026 results. The company reported adjusted EPS of $0.75 vs $0.74 expected and revenue of $631.5M vs about $627M, but revenue rose only 0.9% year over year. Non-GAAP operating margin improved to 39.7%. Paying users reached 18.19M. William Blair upgraded to Market Perform, while consensus remains Sell.

$HLMedAI 8/10

Hecla Mining Q2 Earnings Call Highlights

Hecla Mining reported Q2 financial and operating updates. The company ended the quarter with $483 million cash, about $472 million net cash, and an essentially undrawn $225 million revolver. It projected 2026 free cash flow of about $500 million at $50 silver and $3,500 gold, and raised Greens Creek silver guidance to 8.0-8.3 million ounces. Production guidance was adjusted for Lucky Friday and Keno Hill.

$RCELHighAI 9/10

Avita Medical Shares Surge After Record Second-Quarter Performance

Avita Medical (NASDAQ:RCEL) shares rose about 21.7% in premarket after it reported record Q2 results. Revenue was $21.7M, up 18% YoY and about 8% above estimates. Adjusted loss per share narrowed to $0.25 vs $0.30 expected. Full-year 2026 revenue guidance raised to $86M-$89M and cash-flow breakeven targeted for Q4 2026. BTIG upgraded to Buy with a $7.00 target.